Aurora Spine Corporation
ASG.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 16.90M | 16.09M | 15.58M | 14.52M | 14.09M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.90M | 16.09M | 15.58M | 14.52M | 14.09M |
| Cost of Revenue | 6.70M | 6.40M | 6.41M | 6.31M | 6.34M |
| Gross Profit | 10.21M | 9.68M | 9.17M | 8.21M | 7.74M |
| SG&A Expenses | 8.83M | 8.50M | 8.16M | 7.54M | 7.34M |
| Depreciation & Amortization | 1.04M | 1.09M | 1.12M | 1.05M | 1.10M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.36M | 16.86M | 16.67M | 16.02M | 16.08M |
| Operating Income | -457.50K | -771.70K | -1.10M | -1.50M | -1.99M |
| Income Before Tax | -635.50K | -956.20K | -1.28M | -1.68M | -2.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.64 | -0.96 | -1.28 | -1.68 | -2.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -635.50K | -956.20K | -1.28M | -1.68M | -2.23M |
| EBIT | -457.50K | -771.70K | -1.10M | -1.50M | -1.99M |
| EBITDA | 244.20K | -4.00K | -294.80K | -763.00K | -1.21M |
| EPS Basic | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| EPS Diluted | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 307.76M | 299.40M | 290.95M | 282.26M | 273.77M |
| Average Diluted Shares Outstanding | 307.76M | 299.40M | 290.95M | 282.26M | 273.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |